About: Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1997 (uk) im September 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1997 (ast) scientific article published on 01 September 1997 (en)
publication date	wds:Q57244377-B9EBD74B-8E6B-49E5-99F3-2191392C8B53
publication date	1997-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57244377-4F4C7AC2-2763-4342-858E-6256DBE38753
language of work or name	English
author name string	wds:Q57244377-431930D4-2766-4AE8-8964-5D2F05935BF7 wds:Q57244377-5DD753FD-538A-4BAC-B2B7-8257FD630B6D wds:Q57244377-634CAB47-71D1-495E-A051-01E16178390E wds:Q57244377-721227CB-B550-4F69-BC71-9AE6BC8C7D4D wds:Q57244377-75BFFCE5-8FA3-462A-A5ED-9AF1DF03B479 wds:Q57244377-887484EF-42E5-48F6-ABE1-2CEF0E26D052 wds:Q57244377-B6548A01-0AD0-49F9-9B1A-08E45DA92080
author name string	J Auwerx J C Fruchart C Fievet J R Paterniti M R Briggs A M Lefebvre I Leitersdorf
rdfs:label	Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates (en) Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates (nl)
skos:prefLabel	Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates (en) Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates (nl)
name	Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates (en) Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates (nl)
author	wds:Q57244377-CFAC6789-2215-4108-A089-4E1898B709B3 wds:Q57244377-D94A8F2E-C5A2-4B05-BA23-25707CBF6075
author	Bart Staels Julia Peinado-Onsurbe
title	wds:Q57244377-3FFAE38A-8E44-4794-A819-BC7D352EE9B8
title	Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates (en)
page(s)	wds:Q57244377-98DA4074-22BE-48FC-BEEB-7A2A07970EAC
page(s)	1756-1764
instance of	wds:Q57244377-AA519D1E-7384-4080-8D6C-8C75620FF568
instance of	scholarly article
main subject	wds:Q57244377-59510FC2-E3D8-41D5-8B9B-957E4B1D886C
main subject	lipoprotein
PubMed ID	wds:Q57244377-ED35F1D6-886A-4401-8365-91F08BF78573
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9327774
PubMed ID	9327774
published in	wds:Q57244377-A6E5FE86-2E39-448B-9C5E-F3B09A4DB120
published in	Arteriosclerosis, Thrombosis, and Vascular Biology
issue	wds:Q57244377-AB865716-D893-4584-96EE-69AB6CD5E100
volume	wds:Q57244377-C09DB3FF-DF93-43E2-BC7A-9BA4A8FF674D
issue	9
volume	17
DOI	wds:Q57244377-DA365888-88D2-492E-BF9F-A498FDAAF1DD
DOI	http://dx.doi.org/10.1161/01.ATV.17.9.1756
DOI	10.1161/01.ATV.17.9.1756
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57244377
is cites work of	Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus SRC-1 and TIF2 control energy balance between white and brown adipose tissues Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? Peroxisome proliferator activated receptors and lipoprotein metabolism PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin Actions of PPARgamma agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids. Activation of PPARdelta alters lipid metabolism in db/db mice. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4 alpha, and PGC-1 alpha. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation Micronized fenofibrate: a new fibric acid hypolipidemic agent Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution Rosiglitazone Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Peroxisome proliferator-activated receptorα agonists differentially regulate inhibitor of DNA binding expression in rodents and human cells Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats Evolving pathophysiologic concepts in nonalcoholic steatohepatitis Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia. Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance in their fetuses and neonates. Rat model of familial combined hyperlipidemia as a result of comparative mapping Regulation of p85alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells The safety of rosiglitazone in the treatment of Type 2 diabetes Triglyceride-lowering effect of respiratory uncoupling in white adipose tissue Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes New approaches in the treatment of type 2 diabetes Novel insulin sensitizers: pharmacogenomic aspects Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats. Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat. Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software